Navigation Links
Vasogen to Webcast Presentations at Three Upcoming Healthcare Conferences
Date:11/1/2007

MISSISSAUGA, ON, Nov. 1 /PRNewswire-FirstCall/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today announced that Vasogen's management will present at the following investor conferences in November:

Acumen BioFin Rodman & Renshaw 9th Annual Global Healthcare Conference,

The New York Palace Hotel

Tuesday, November 6, 2007 at 11:40 a.m. (ET)

JMP Securities Healthcare Focus Conference, Four Seasons Hotel, Boston

Tuesday, November 13, 2007 at 2:00 p.m. (ET)

Lazard Capital Markets Fourth Annual Healthcare Conference,

The New York Palace Hotel

Tuesday, November 27, 2007 at 1:00 p.m. (ET)

The presentations will be webcast live and available for replay from Vasogen's website, http://www.vasogen.com.

About Vasogen:

Vasogen is a biotechnology company engaged in the research and commercial development of therapies designed to target the destructive inflammatory process associated with the development and progression of cardiovascular and neurodegenerative disorders. The Company's lead product, the Celacade(TM) System, is designed to activate the immune response to apoptosis - an important physiological process that regulates inflammation. Celacade is in late-stage development for the treatment of chronic heart failure and has received European regulatory approval under the CE Mark for this indication. Vasogen is also developing a new class of drugs for the treatment of certain neuro-inflammatory disorders. VP025 is the lead drug candidate from this new class.

Certain statements contained in this press release, the upcoming presentations and webcasts, or elsewhere in our public documents constitute "forward-looking
'/>"/>

SOURCE Vasogen Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Sonic Foundry to Webcast Bridge Arch Floating Down Mississippi
2. New Sonic Foundry search engine finds words, phrases in video presentations
3. Sonic Foundry creates search engine for 7,000 expert video presentations
4. InvestMidWest calls for business presentations
5. BxVideo designs Web hosting service for Sonic Foundry media presentations
6. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
7. The TripleMaster PCR System for three different amplifications
8. Cloning Based on Efficient Three-Fragment Assembly DNA Ligation
9. Three Micron TSK-GEL ODS-100V Columns for High Throughput LCMS
10. Three finalists named for UW-Madison CIO
11. Three state businesses receive technology grants

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , , CALGARY, Dec. 2 /PRNewswire-F...or the "Company") (TSX:ONC; NASDAQ: ONCY ) announc...nounced unit offering, the underwriters have exerc...ased an additional 637,500 units. Each unit is com...re purchase warrant, and was sold at a price of US...
(Date:12/2/2009)... , , SINGAPORE, Dec. 2 /PRNewswire/...ns on its novel oral JAK2 inhibitor, SB1518, at Th...ng and Exposition in New Orleans. ,, Data will ...e 1 dose-escalation trial of SB1518 detailing its ...ynamic (PK/PD) profile in dose levels ranging from...
(Date:12/2/2009)... , The Scientist, a leadi... ranked Photometrics’ Evolve “Intellig...on’s “Top 10 Innovations of 2009. , ... The Evolve ™ EMCCD camera from Photometr...formance CCD and EMCCD cameras for the life scienc...
(Date:12/1/2009)... , , NEW YORK, Dec. 1 /PRNewswire/ ...search report is available in its catalogue: ,,..., http://www.reportlinker.com/p0164431/Industria...ustrial Enzymes market is an oligopoly with few st... in niche market activities. Keen competition and ...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10
...., May 2 Osteotech, Inc.,(Nasdaq: OSTE ), a lead...,regenerative healing, announced today that its Pl...Reconstruction Program led by Dr. Jeffrey Hollinge...ch was prepared under the,auspices of the New Jers...,Rutgers University, is part of a multi-institutio...
...M) Technology Raising the Bar in Motion Preservati...hnology,Inc., a leader in innovative medical devic...ion of its next generation cervical total disc,rep.... The surgeries were,performed by Drs. Hansen Yuan...ients with degenerative disc disease (DDD) otherwi...
...l/Webcast to be Held Wednesday, May 7, 2008 at 10:...echnologies, Inc. (Nasdaq: EMIS ) will host a con...the first quarter ended March 31, 2008 on,Wednesda...f the conference call can be accessed through the,...The live conference call dial-in,number is: 1-800-...
Other Biology Technology:Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine 2Osteotech's Plexur(R) Technology to Be Used in Craniofacial Reconstruction Program Funded by the Armed Forces Institute of Regenerative Medicine 3Pioneer(R) Surgical Technology Announces First Human Implants of its NuNec(TM) Cervical Arthroplasty Device 2Emisphere Technologies, Inc. Announces Conference Call for First Quarter 2008 Financial Results 2
(Date:12/3/2009)...ntents of this message: , , Preliminary Press...to California Academy of Sciences museum, Attent... NCSWA holiday dinner registration deadline 10 D... News Media Registration Form pre-registration dea..., For important information regarding visas for ...
(Date:12/3/2009)...and Rapids, Mich. (Dec. 3, 2009) Van Andel Rese...precisely how the plant hormone abscisic acid (ABA...ond to environmental stresses such as drought and ...ature , could help engineer crops that thrive in h...al food shortages. The findings could also have i...
(Date:12/3/2009)...rest dwellers must be included in the design of th...void a humanitarian crisis, according to a scienti...in Nature , Dr Simon Lewis argues that at least 5...openhagen, known as REDD (Reducing Emissions from ...forest dwellers directly, and their property right...
Breaking Biology News(10 mins):AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Forest deal at Copenhagen must avoid creating 'carbon refugees' 2Bridges To Recovery a one of a Kind Los Angeles Facility Providing In Patient Psychiatric Treatment Acquires License To Provide Additional Beds 58731 1Bridges To Recovery a one of a Kind Los Angeles Facility Providing In Patient Psychiatric Treatment Acquires License To Provide Additional Beds 58731 2Intercept Pharmaceuticals FXR Agonist INT 747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty 5182 1Intercept Pharmaceuticals FXR Agonist INT 747 Meets Primary Endpoint in a Phase II Clinical Trial in Type 2 Diabetic Patients with Nonalcoholic Fatty 5182 2Energy autonomous sensors for aircraft 14324 1Energy autonomous sensors for aircraft 14324 2
...er Current , M. Belkin, A. Snezhko, I.S. Aranson, ...ng) , Physicists at Argonne National Laboratory h...er and subjected to an alternating magnetic field ... the flow of the surrounding fluid. Current incarn... long, but the team envisions much smaller version...
...ssful academic entrepreneurs has teamed up with th... and development in membrane biology to pharmaceut...ny Marchington, who turned his spin-out company Ox...rk alongside the Universitys new Centre for Integr...ontracts with industry, based on Leeds world-class...
...EASE , Spinning a new role for CDs and CD player...he hardware used to play these popular audio and v...s a new generation of portable, inexpensive instru...ased testing, scientists in Spain are reporting in...semi-monthly journal. CD technology could be adap...
Other Biology News:Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 2Magnetic snakes control fluids, gravity-defying droplets, and solving a dragonfly mystery 3New partnership offers outsourced R&D in membrane biology 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 2American Chemical Society's Weekly PressPac -- Sept. 19, 2007 3American Chemical Society's Weekly PressPac -- Sept. 19, 2007 4American Chemical Society's Weekly PressPac -- Sept. 19, 2007 5American Chemical Society's Weekly PressPac -- Sept. 19, 2007 6American Chemical Society's Weekly PressPac -- Sept. 19, 2007 7American Chemical Society's Weekly PressPac -- Sept. 19, 2007 8
Normal Porcine Serum from Equitech-Bio
3-O-Methylguanosine 5-Triphosphate, Sodium from GE Healthcare, formerly Amersham Biosciences
Porcine Serum from Innovative Research
Rat Tissue Array: Brain, heart, kidney, liver, lung, muscle, spleen and stomach, each tissue from 10 female and 10 male, respectively from BioChain
Biology Products: